G1 Therapeutics Statistics
Total Valuation
CNBB has a market cap or net worth of 87.55 million.
| Market Cap | 87.55M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Tuesday, July 15, 2025.
| Earnings Date | Jul 15, 2025 |
| Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
CNBB has 2.09 million shares outstanding. The number of shares has decreased by -0.67% in one year.
| Current Share Class | 2.09M |
| Shares Outstanding | 2.09M |
| Shares Change (YoY) | -0.67% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.02% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 7.72.
| PE Ratio | 7.72 |
| Forward PE | n/a |
| PS Ratio | 1.69 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | 8.25 |
| P/OCF Ratio | 6.91 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.95 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.87%.
| Return on Equity (ROE) | 11.87% |
| Return on Assets (ROA) | 0.92% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CNBB has paid 2.82 million in taxes.
| Income Tax | 2.82M |
| Effective Tax Rate | 19.59% |
Stock Price Statistics
The stock price has increased by +22.01% in the last 52 weeks. The beta is 0.33, so CNBB's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +22.01% |
| 50-Day Moving Average | 42.01 |
| 200-Day Moving Average | 41.07 |
| Relative Strength Index (RSI) | 56.14 |
| Average Volume (20 Days) | 615 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, CNBB had revenue of 51.74 million and earned 11.58 million in profits. Earnings per share was 5.42.
| Revenue | 51.74M |
| Gross Profit | 51.74M |
| Operating Income | 14.41M |
| Pretax Income | 14.41M |
| Net Income | 11.58M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 5.42 |
Balance Sheet
The company has 71.97 million in cash and 73.78 million in debt, giving a net cash position of -1.81 million or -0.87 per share.
| Cash & Cash Equivalents | 71.97M |
| Total Debt | 73.78M |
| Net Cash | -1.81M |
| Net Cash Per Share | -0.87 |
| Equity (Book Value) | 99.65M |
| Book Value Per Share | 47.95 |
| Working Capital | -1.04B |
Cash Flow
In the last 12 months, operating cash flow was 12.67 million and capital expenditures -2.06 million, giving a free cash flow of 10.61 million.
| Operating Cash Flow | 12.67M |
| Capital Expenditures | -2.06M |
| Free Cash Flow | 10.61M |
| FCF Per Share | 5.07 |
Margins
| Gross Margin | n/a |
| Operating Margin | 27.84% |
| Pretax Margin | 27.84% |
| Profit Margin | 22.39% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 20.51% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 3.35%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 3.35% |
| Dividend Growth (YoY) | 2.94% |
| Years of Dividend Growth | 8 |
| Payout Ratio | 25.59% |
| Buyback Yield | 0.67% |
| Shareholder Yield | 4.00% |
| Earnings Yield | 13.23% |
| FCF Yield | 12.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |